125 related articles for article (PubMed ID: 2738264)
21. The effects of SUN 1165, a novel sodium channel blocker, on ischemia-induced mitochondrial dysfunction and leakage of lysosomal enzymes in canine hearts.
Sugiyama S; Hanaki Y; Ogawa T; Hieda N; Taki K; Ozawa T
Biochem Biophys Res Commun; 1988 Dec; 157(2):433-9. PubMed ID: 2849430
[TBL] [Abstract][Full Text] [Related]
22. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro.
Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F
Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527
[TBL] [Abstract][Full Text] [Related]
23. Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with lidocaine.
Bonaduce D; Ferrara N; Abete P; Longobardi G; Leosco D; Canonico V; Morgano G; Rengo F
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):19-29. PubMed ID: 3827408
[TBL] [Abstract][Full Text] [Related]
24. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
Ogawa S; Mitamura H; Katoh H
Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
[TBL] [Abstract][Full Text] [Related]
25. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
[TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
[TBL] [Abstract][Full Text] [Related]
27. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K
Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
[TBL] [Abstract][Full Text] [Related]
28. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N
Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065
[TBL] [Abstract][Full Text] [Related]
29. The cardioprotective effect of gamma-glutamylcysteine ethyl ester during coronary reperfusion in canine hearts.
Nishinaka Y; Kitahara S; Sugiyama S; Yokota M; Saito H; Ozawa T
Br J Pharmacol; 1991 Dec; 104(4):805-10. PubMed ID: 1810596
[TBL] [Abstract][Full Text] [Related]
30. [Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].
Hidaka T; Inoue T; Komoriya K; Hayashi Y; Inomata N
Nihon Yakurigaku Zasshi; 2000 May; 115(5):295-308. PubMed ID: 10872181
[TBL] [Abstract][Full Text] [Related]
31. Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts.
Iwasaki S; Araki H; Yamakawa T; Nishi K; Miyauchi Y
Arch Int Pharmacodyn Ther; 1989; 300():174-85. PubMed ID: 2619422
[TBL] [Abstract][Full Text] [Related]
32. Intropic effects of several antiarrhythmic drugs.
Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine.
Kondo T; Yamaki M; Kubota I; Tachibana H; Tomoike H
J Am Coll Cardiol; 1997 Jun; 29(7):1639-44. PubMed ID: 9180130
[TBL] [Abstract][Full Text] [Related]
34. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
Krejcy K; Krumpl G; Todt H; Raberger G
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Spinelli W; Hoffman BF
Circ Res; 1989 Dec; 65(6):1565-79. PubMed ID: 2510953
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandin I2 analogue and propranolol prevent ischaemia induced mitochondrial dysfunction through the stabilisation of lysosomal membranes.
Hieda N; Toki Y; Sugiyama S; Ito T; Satake T; Ozawa T
Cardiovasc Res; 1988 Mar; 22(3):219-25. PubMed ID: 3048692
[TBL] [Abstract][Full Text] [Related]
37. The effect of Coenzyme Q10 on reperfusion injury in canine myocardium.
Nagai S; Miyazaki Y; Ogawa K; Satake T; Sugiyama S; Ozawa T
J Mol Cell Cardiol; 1985 Sep; 17(9):873-84. PubMed ID: 4046048
[TBL] [Abstract][Full Text] [Related]
38. Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart.
Verdouw PD; Deckers JW; Conrad GJ
J Cardiovasc Pharmacol; 1979; 1(4):473-86. PubMed ID: 94625
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
[TBL] [Abstract][Full Text] [Related]
40. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
